Zulfa Omer
Clinical trials sponsored by Zulfa Omer, explained in plain language.
-
New study tests pausing treatment for blood cancer patients
Disease control Recruiting nowThis study is for people with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL). It compares taking the drug venetoclax continuously versus taking it in cycles (on and off), both combined with another drug called acalabrutinib. The goal is to see if t…
Phase: PHASE2 • Sponsor: Zulfa Omer • Aim: Disease control
Last updated May 03, 2026 21:30 UTC
-
New hope for CLL patients: consolidation therapy aims for deeper remission
Disease control Recruiting nowThis study tests whether adding the drug epcoritamab after standard treatment can help people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) achieve a deeper remission. About 22 adults who have already received at least 12 months of a BTK inhibitor (a…
Phase: PHASE2 • Sponsor: Zulfa Omer • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC